| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Multi-kinase-IN-2 |
Sparfosic |
51321-79-0 |
详细
|
| BAY32-5915 |
8-羟基喹啉-2-羧酸 |
1571-30-8 |
详细
|
| β-Sitostenone |
豆甾-4-烯-3-酮 |
1058-61-3 |
详细
|
| NB-360 |
2-Pyridinecarboxamide, N-[3-[(3R,6R)-5-amino-3,6-dihydro-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl- |
1262857-73-7 |
详细
|
| Nifeviroc |
Nifeviroc |
934740-33-7 |
详细
|
| (Rac)-BRD0705 |
化合物 T12664 |
1597440-03-3 |
详细
|
| Cyclotriazadisulfonamide |
1,5,9-三氮杂环十二烷,3-亚甲基-1,5-双[(4-甲基苯基)磺酰基]-9-(苯基甲基)- |
182316-44-5 |
详细
|
| HBC |
Benzeneacetonitrile, 4-cyano-α-[[4-[(2-hydroxyethyl)methylamino]phenyl]methylene]- |
156840-13-0 |
详细
|
| GZD856 formic |
化合物 GZD856 FORMIC |
2804039-78-7 |
详细
|
| Cinnamaldehyde |
肉桂醛 |
104-55-2 |
详细
|
| Keap1-Nrf2-IN-16 |
(R)-5-羟基-1,7-二苯基-3-庚酮 |
100761-20-4 |
详细
|
| SMANT hydrochloride |
化合物T23370 |
1177600-74-6 |
详细
|
| PDE10-IN-1 |
3-Methyl-2-((1S,2S)-2-(quinolin-2-yl)cyclopropyl)-3H-iMidazo[4,5-f]quinoline |
1516896-09-5 |
详细
|
| Pembrolizumab |
派姆单抗 |
1374853-91-4 |
详细
|
| AKT-IN-6 |
INCB-047775 |
1430056-54-4 |
详细
|
| 3-Hydroxy-2-methylpyridine |
3-羟基-2-甲基吡啶 |
1121-25-1 |
详细
|
| RIPK3-IN-1 |
化合物 RIPK3-IN-1 |
2361139-70-8 |
详细
|
| JAB-3068 hydrochloride |
|
2169223-49-6 |
详细
|
| AKT-IN-1 |
6-[4-(1-氨基环丁基)苯基]-5-苯基-3-吡啶甲酰胺 |
1357158-81-6 |
详细
|
| RO0270608 |
(S)-2-(2-氯-6-甲基苯甲酰氨基)-3-(4-(2,6-二氯苯甲酰氨基)苯基)丙酸 |
220846-33-3 |
详细
|
| Flunarizine |
NaV1.7 inhibitor-1 |
1494585-79-3 |
详细
|
| Benpyrine |
BENPYRINE |
2550398-89-3 |
详细
|
| AZ3976 |
化合物 T23764 |
1418747-15-5 |
详细
|
| L-Ascorbic acid- |
化合物HOMO-VK-II-36 |
1479049-35-8 |
详细
|
| Golgicide A-2 |
GOLGICIDE A-2 |
1394285-50-7 |
详细
|
| BMS-986202 |
BMS-986202 |
1771691-34-9 |
详细
|
| Thioquinapiperifil dihydrochloride |
KF-31327 |
204077-66-7 |
详细
|
| Sofosbuvir impurity G |
索氟布韦杂质 |
1337482-15-1 |
详细
|
| PARP-2-IN-3 |
B014 |
1215208-59-5 |
详细
|
| CWP232228 |
化合物CWP232228 |
1144044-02-9 |
详细
|
| AMG8380 |
PF-06649298 |
1854061-16-7 |
详细
|
| XEN723 |
1072803-08-7 |
1072803-08-7 |
详细
|
| dichloride |
|
855291-54-2 |
详细
|
| RIP2 Kinase Inhibitor 3 |
RIP2 Kinase Inhibitor 3 |
1398053-50-3 |
详细
|
| Dimethyl malonate |
丙二酸二甲酯 |
108-59-8 |
详细
|
| MAT2A inhibitor 4 |
化合物T9262 |
1391934-91-0 |
详细
|
| GNE-1858 |
1H-Pyrazolo[4,3-c]pyridin-6-amine, N-[2-(3,3-difluoro-1-pyrrolidinyl)-6-(3-pyrrolidinyl)-4-pyrimidinyl]-1-(1-methylethyl)- |
2680616-96-8 |
详细
|
| TRPC6-IN-3 |
化合物 TRPC6-IN-3 |
2311863-36-0 |
详细
|
| Bufarenogin |
伪异沙蟾毒精 |
17008-65-0 |
详细
|
| PF-04880594 |
化合物AD57 |
1093380-42-7 |
详细
|
| MRT-83 |
[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]- |
1263131-92-5 |
详细
|
| Alirocumab |
阿利库单抗 |
1245916-14-6 |
详细
|
| CL264 |
CL264 |
1510712-69-2 |
详细
|
| Tyk2-IN-7 |
TYK2-IN-7 (COMPOUND 48) |
1609391-90-3 |
详细
|
| 2-Iodoacetamide |
2-碘乙酰胺 |
144-48-9 |
详细
|
| WEE1-IN-3 |
JUN76288 |
2272976-28-8 |
详细
|
| XMU-MP-3 |
|
2031152-08-4 |
详细
|
| FTT5 |
FTT5 |
2328129-27-5 |
详细
|
| FGTI-2734 mesylate |
|
2702297-24-1 |
详细
|
| Synucleozid hydrochloride |
|
2741856-68-6 |
详细
|
| Galloylpaeoniflorin |
没食子酰芍药苷 |
122965-41-7 |
详细
|
| VU0359595 |
(1R,2R)-N-([S]-1-{4-[5-BROMO-2-OXO-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOL-1-YL]PIPERIDIN-1-YL}PROPAN-2-YL)-2-PHENYLCYCLOPROPANECARBOXAMIDE;VU0359595 |
1246303-14-9 |
详细
|
| N-trans-Caffeoyltyramine |
N-trans-caffeoyltyramine |
103188-48-3 |
详细
|
| XD14 |
CS-2672 |
1370888-71-3 |
详细
|
| Lu AE98134 |
LU AE98134 |
849000-18-6 |
详细
|
| CFTR corrector 6 |
DAPAGLIFLOZIN |
2226970-01-8 |
详细
|
| 3,5-Di-tert-butylphenol |
3,5-二叔丁基苯酚 |
1138-52-9 |
详细
|
| Cbl-b-IN-1 |
CBL-B-IN-1 |
2368841-84-1 |
详细
|
| FT206 |
FT206 |
2278274-34-1 |
详细
|
| Posenacaftor sodium |
POSENACAFTOR SODIUM |
2095064-06-3 |
详细
|
| Povorcitinib phosphate |
POVORCITINIB磷酸盐 |
1637677-33-8 |
详细
|
| Hispolon |
HISPOLON |
173933-40-9 |
详细
|
| Chrysin 6-C-arabinoside 8-C-glucoside |
白杨素 6-C-阿拉伯糖 8-C-葡萄糖苷 |
185145-33-9 |
详细
|
| SB-747651A dihydrochloride |
SB-747651A二盐酸盐 |
1781882-72-1 |
详细
|
| MLT-943 |
MLT943 |
1832576-04-1 |
详细
|
| Bisindolylmaleimide V |
双吲哚马来酰亚胺 |
113963-68-1 |
详细
|
| Bcl-xL antagonist 2 |
BCL-XL拮抗剂2 |
1235032-75-3 |
详细
|
| 3-Pyridinemethanol |
3-吡啶甲醇 |
100-55-0 |
详细
|
| (R)-Posenacaftor sodium |
(R)-POSENACAFTOR SODIUM |
2095064-09-6 |
详细
|
| CCT369260 |
|
2647503-57-7 |
详细
|
| MitoTam bromide, hydrobromide |
MITOTAM BROMIDE, HYDROBROMIDE |
1634624-73-9 |
详细
|
| GSM-1 |
4-Piperidineacetic acid, 1-[(1R)-1-(4-chlorophenyl)-4-methylpentyl]-2-[4-(trifluoromethyl)phenyl]-, (2S,4R)- |
884600-68-4 |
详细
|
| IMT1B |
化合物IMT1B |
2304621-06-3 |
详细
|
| 13,21-Dihydroeurycomanone |
Picras-3-ene-2,16-dione, 11,20-epoxy-1,11,12,14,15-pentahydroxy-, (1β,11β,12α,15β)- |
129587-06-0 |
详细
|
| CDK-IN-9 |
|
1903783-77-6 |
详细
|
| BCL6-IN-4 |
BCL6-IN-4 |
2253879-65-9 |
详细
|
| JAK2-IN-7 |
JAK2-IN-7 |
2593402-36-7 |
详细
|
| PB1 |
PB1 |
188714-28-5 |
详细
|
| Pitavastatin sodium |
Β-香树脂醇乙酸酯 |
1616-93-9 |
详细
|
| Chrysosplenol D |
猫眼草酚 |
14965-20-9 |
详细
|
| Decapeptide-12 |
SIRT-IN-1 |
1431411-60-7 |
详细
|
| EHT 5372 |
化合物 EHT 5372 |
1425945-63-6 |
详细
|
| Tazofelone |
化合物TAZOFELONE |
107902-67-0 |
详细
|
| (E/Z)-Sivopixant |
化合物(E/Z)-SIVOPIXANT |
1640808-39-4 |
详细
|
| X77 |
化合物 X77 |
2455518-33-7 |
详细
|
| (S)-Willardiine |
AMPA RECEPTOR MODULATOR-2 |
2034181-36-5 |
详细
|
| TLR7/8-IN-1 |
TLR7/8-IN-1 |
2205095-75-4 |
详细
|
| Arnicolide D |
2-(2-氨基-4-甲基-5-嘧啶基)-ALPHA,ALPHA-二甲基-4-(4-吗啉基)噻吩并[3,2-D]嘧啶-6-甲醇 |
1033739-92-2 |
详细
|
| AM103 |
AM 103 |
1147872-22-7 |
详细
|
| PR-104A |
PR 104A |
680199-06-8 |
详细
|
| BU224 hydrochloride |
化合物BU 226 HYDROCHLORIDE |
1186195-56-1 |
详细
|
| AChE-IN-27 |
化合物WAY-298592 |
177028-90-9 |
详细
|
| MitoTam iodide, hydriodide |
MITOTAM IODIDE, HYDRIODIDE |
1634624-74-0 |
详细
|
| TPN171 |
TPN171 |
1229018-87-4 |
详细
|
| Wnt pathway activator 2 |
Wnt pathway activator 2 |
1360540-82-4 |
详细
|
| D-Galacturonic acid hydrate |
甲壳素 |
1398-61-4 |
详细
|
| LCAHA |
Cholan-24-amide, N,3-dihydroxy-, (3α,5β)- |
117094-40-3 |
详细
|
| KW-8232 |
KW-8232 |
217813-15-5 |
详细
|
| SIRT2-IN-8 |
奥司他韦杂质B(2-叠氮杂合物) |
115687-05-3 |
详细
|
| Minzasolmin |
化合物 MINZASOLMIN |
1802518-92-8 |
详细
|